APA (7th ed.) Citation

Desguerre, I., Barrois, R., Audic, F., Barnerias, C., Chabrol, B., Davion, J. B., . . . Cances, C. (2024). Real-world multidisciplinary outcomes of onasemnogene abeparvovec monotherapy in patients with spinal muscular atrophy type 1. Orphanet Journal of Rare Diseases, 19(1), 1. https://doi.org/10.1186/s13023-024-03326-3

Chicago Style (17th ed.) Citation

Desguerre, Isabelle, et al. "Real-world Multidisciplinary Outcomes of Onasemnogene Abeparvovec Monotherapy in Patients with Spinal Muscular Atrophy Type 1." Orphanet Journal of Rare Diseases 19, no. 1 (2024): 1. https://doi.org/10.1186/s13023-024-03326-3.

MLA (9th ed.) Citation

Desguerre, Isabelle, et al. "Real-world Multidisciplinary Outcomes of Onasemnogene Abeparvovec Monotherapy in Patients with Spinal Muscular Atrophy Type 1." Orphanet Journal of Rare Diseases, vol. 19, no. 1, 2024, p. 1, https://doi.org/10.1186/s13023-024-03326-3.